Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-003874
Filing Date
2025-04-11
Accepted
2025-04-11 17:00:14
Documents
1
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3481
  Complete submission text file 0001641172-25-003874.txt   4897
Mailing Address 8200 WILSHIRE BLVD BEVERLY HILLS CALIFORNIA CA 90211
Business Address
D'Alessio Lorraine Pamela (Reporting) CIK: 0001905593 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41615 | Film No.: 25832873

Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Issuer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)